View All Documents & Correspondence
Freeze Dried Viral Vaccine Compositions And Method Of Manufacturing Thereof
Abstract: The present disclosure relates to field of lyophilized/freeze-dried viral vaccine composition and methods for manufacturing and obtaining the vaccine composition comprising live attenuated flavivirus as vaccine antigen selected from a group of yellow fever virus, dengue virus, Japanese encephalitis (JE) virus, Kunjin virus, West Nile (WN) virus, tick-borne encephalitis (TBE) virus, St. Louis encephalitis virus, Murray Valley encephalitis virus, Zika virus vaccine antigen; and stabilizers comprising sugar or sugar alcohol; amino acids; lactalbumin hydrolysate and gelatin. Post reconstitution, the composition preserves the desired characteristics of the virus, including immunogenicity and stability. The composition of the present disclosure can be safely administered subcutaneously or intramuscularly such that the vaccine composition induces complete immune response to yellow fever virus infectious agent and meets the criterion for the seroprotection for the said immunogenic components comprising yellow fever virus.
Notices, Deadlines & Correspondence
Patent Information
Applicants
SERUM INSTITUTE OF INDIA PRIVATE LIMITED
Inventors
1. RAJEEV MHALASAKANT DHERE
2. MILAN SHOMENATH GANGULY
3. PARIKSHIT DHARAMPAL TYAGI
4. UMESH GORAKH SAGAR
5. SWAPNIL PRABHAKAR NARALE
6. YASHODHAN DILIP ANASPURE
7. SHAM RAMDAS TUPE
8. CYRUS SOLI POONAWALLA
9. ADAR CYRUS POONAWALLA
Specification
Description:PLEASE SEE ATTACHED , Claims:PLEASE SEE ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202321051767-STATEMENT OF UNDERTAKING (FORM 3) [01-08-2023(online)].pdf | 2023-08-01 |
| 2 | 202321051767-FORM 1 [01-08-2023(online)].pdf | 2023-08-01 |
| 3 | 202321051767-DECLARATION OF INVENTORSHIP (FORM 5) [01-08-2023(online)].pdf | 2023-08-01 |
| 4 | 202321051767-COMPLETE SPECIFICATION [01-08-2023(online)].pdf | 2023-08-01 |
| 5 | 202321051767-Proof of Right [08-09-2023(online)].pdf | 2023-09-08 |
| 6 | 202321051767-FORM-26 [08-09-2023(online)].pdf | 2023-09-08 |
| 7 | 202321051767-FORM-9 [22-09-2023(online)].pdf | 2023-09-22 |
| 8 | 202321051767-Power of Attorney [29-09-2023(online)].pdf | 2023-09-29 |
| 9 | 202321051767-Form 1 (Submitted on date of filing) [29-09-2023(online)].pdf | 2023-09-29 |
| 10 | 202321051767-Covering Letter [29-09-2023(online)].pdf | 2023-09-29 |
| 11 | 202321051767-CORRESPONDENCE(IPO)(WIPO DAS)-06-10-2023.pdf | 2023-10-06 |
| 12 | 202321051767-FORM 18A [11-10-2023(online)].pdf | 2023-10-11 |
| 13 | 202321051767-REQUEST FOR CERTIFIED COPY [03-11-2023(online)].pdf | 2023-11-03 |
| 14 | 202321051767-CORRESPONDENCE(IPO)-(CERTIFIED LETTER)-07-11-2023.pdf | 2023-11-07 |
| 15 | 202321051767-FER.pdf | 2023-11-22 |
| 16 | 202321051767-FORM 4 [01-05-2024(online)].pdf | 2024-05-01 |
| 17 | 202321051767-FORM 3 [01-05-2024(online)].pdf | 2024-05-01 |
| 18 | 202321051767-MARKED COPIES OF AMENDEMENTS [15-05-2024(online)].pdf | 2024-05-15 |
| 19 | 202321051767-FORM 13 [15-05-2024(online)].pdf | 2024-05-15 |
| 20 | 202321051767-FER_SER_REPLY [15-05-2024(online)].pdf | 2024-05-15 |
| 21 | 202321051767-COMPLETE SPECIFICATION [15-05-2024(online)].pdf | 2024-05-15 |
| 22 | 202321051767-CLAIMS [15-05-2024(online)].pdf | 2024-05-15 |
| 23 | 202321051767-AMMENDED DOCUMENTS [15-05-2024(online)].pdf | 2024-05-15 |
| 24 | 202321051767-US(14)-HearingNotice-(HearingDate-06-05-2025).pdf | 2025-04-02 |
| 25 | 202321051767-Correspondence to notify the Controller [30-04-2025(online)].pdf | 2025-04-30 |
| 26 | 202321051767-Written submissions and relevant documents [19-05-2025(online)].pdf | 2025-05-19 |
| 27 | 202321051767-PatentCertificate28-05-2025.pdf | 2025-05-28 |
| 28 | 202321051767-IntimationOfGrant28-05-2025.pdf | 2025-05-28 |
Search Strategy
| 1 | 1searchstrgy_3_11E_21-11-2023.pdf |